NELFCD and cancer: The 847 miRNAs included 334 miRNAs targeting “cancer immunity-related genes”, distributed as 98 miRNAs related to Th-1 status, 123 miRNAs for Th-2 status, 44 miRNAs for T-reg status, 275 miRNAs for stimulatory checkpoints, and 321 miRNAs for inhibitory checkpoints (Fig 1).